Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Fortune Indonesia Tbk (FORU) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Fortune Indonesia TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Fortune Indonesia Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Fortune Indonesia Tbk trades at Rp2,090 (market cap 1T, 328.6K 24h volume). The key difference: Fortune Indonesia Tbk is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Fortune Indonesia Tbk is more actively traded (328.6K versus 41.7K). Which is the better fit depends on your goals.

DGNSFORU
Market Cap
316.25B1T
Volume
41.7K328.6K
Lot
4173.29K
Turnover
9.66M697.02M
Average Price
231.652,121.17
Value
9.66M697.02M
Indicative Equilibrium Price
2302,090
Indicative Equilibrium Volume
2.4K63

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
FORU
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Fortune Indonesia Tbk

PT. Fortune Indonesia, Tbk (the Company) was established under its original name of PT Fortune Indonesia Advertising Company based on Notarial Deed No. 5 of Dian Paramita Tamzil, S.H., dated May 5, 1970.

Read more on FORU